Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 90.

Mok, M.T. S, Zhou, J, Tang, W, Zeng, X, Oliver, A, Ward, Simon and Cheng, A. S.L 2018. CCRK is a novel signalling hub exploitable in cancer immunotherapy. Pharmacology & Therapeutics 186 , pp. 138-151. 10.1016/j.pharmthera.2018.01.008

Henderson, Scott H., West, Ryan A., Ward, Simon E. and Honey, Mark A. 2018. Metal-free selective mono-halodecarboxylation of heteroarenes under mild conditions. Royal Society Open Science 5 (6) , 180333. 10.1098/rsos.180333
file

West, Ryan A., Cunningham, Thomas, Pennicott, Lewis E., Rao, Srinivasa P. S. and Ward, Simon 2018. Toward more drug like inhibitors of trypanosome alternative oxidase. ACS Infectious Diseases 4 (4) , pp. 592-604. 10.1021/acsinfecdis.7b00218
file

Kenyon, Emma J., Kirkwood, Nerissa K., Kitcher, Siân R., O'reilly, Molly, Derudas, Marco, Cantillon, Daire M., Goodyear, Richard J., Secker, Abigail, Baxendale, Sarah, Bull, James C., Waddell, Simon J., Whitfield, Tanya T., Ward, Simon, Kros, Corné J. and Richardson, Guy P. 2017. Identification of ion-channel modulators that protect against aminoglycoside-induced hair cell death. JCI Insight 2 (24) , e96773. 10.1172/jci.insight.96773
file

West, Ryan A., O'Doherty, Oran G., Askwith, Trevor, Atack, John, Beswick, Paul, Laverick, Jamie, Paradowski, Michael, Pennicott, Lewis E., Rao, Srinivasa P.S., Williams, Gareth and Ward, Simon 2017. African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase. European Journal of Medicinal Chemistry 141 , pp. 676-689. 10.1016/j.ejmech.2017.09.067
file

Kirkwood, Nerissa K., O'Reilly, Molly, Derudas, Marco, Kenyon, Emma J., Huckvale, Rosemary, van Netten, Sietse M., Ward, Simon, Richardson, Guy P. and Kros, Corné J. 2017. d-Tubocurarine and berbamine: alkaloids that are permeant blockers of the hair cell's mechano-electrical transducer channel and protect from aminoglycoside toxicity. Frontiers in Cellular Neuroscience 11 , 262. 10.3389/fncel.2017.00262
file

Ward, Simon, Beswick, Paul, Calcinaghi, Novella, Dawson, Lee A, Gartlon, Jane, Graziani, Francesca, Jones, Declan N C, Lacroix, Laurent, Selina Mok, M H, Oliosi, Beatrice, Pardoe, Joanne, Starr, Kathryn, Woolley, Marie L and Harries, Mark H 2017. Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulator. British Journal of Pharmacology 174 (5) , pp. 370-385. 10.1111/bph.13696
file

Phuangsawai, Oraphan, Beswick, Paul, Ratanabunyong, Siriluk, Tabtimmai, Lueacha, Suphakun, Praphasri, Obounchoey, Phongphat, Srisook, Pimonwan, Horata, Natharinee, Chuckowree, Irina, Hannongbua, Supa, Ward, Simon, Choowongkomon, Kiattawee and Gleeson, M. Paul 2016. Evaluation of the anti-malarial activity and cytotoxicity of 2,4-diamino-pyrimidine-based kinase inhibitors. European Journal of Medicinal Chemistry 124 , pp. 896-905. 10.1016/j.ejmech.2016.08.055
file

Meisenberg, Cornelia, Ashour, Mohamed E., El-Shafie, Lamia, Liao, Chunyan, Hodgson, Adam, Pilborough, Alice, Khurram, Syed A., Downs, Jessica A., Ward, Simon and El-Khamisy, Sherif F. 2016. Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan. Nucleic Acids Research 45 (3) , pp. 1159-1176. 10.1093/nar/gkw1026
file

Ocasio, Cory A., Rajasekaran, Mohan B., Walker, Sarah, Le Grand, Darren, Spencer, John, Pearl, Frances M.G., Ward, Simon, Savic, Velibor, Pearl, Laurence H., Hochegger, Helfrid and Oliver, Antony W. 2016. A first generation inhibitor of human Greatwall kinase, enabled by structural and functional characterisation of a minimal kinase domain construct. Oncotarget 7 (44) , pp. 71182-71197. 10.18632/oncotarget.11511
file

Hornyak, P., Askwith, T., Walker, S., Komulainen, E., Paradowski, Michael, Pennicott, L. E., Bartlett, E. J., Brissett, N. C., Raoof, A., Watson, M., Jordan, A. M., Ogilvie, D. J., Ward, Simon, Atack, J. R., Pearl, L. H., Caldecott, K. W. and Oliver, A. W. 2016. Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2. Biochemical Journal 473 (13) , pp. 1869-1879. 10.1042/BCJ20160180
file

Re:Viral Ltd 2016. Spiro-indolines for the treatment and prophylaxis of respiratory syncytial virus infection (RSV). WO2016055780A1. [Patent].

Moore, Thomas O., Paradowski, Michael and Ward, Simon 2016. An atom-efficient and convergent approach to the preparation of NS5A inhibitors by C-H activation. Organic and Biomolecular Chemistry 14 (12) , pp. 3307-3313. 10.1039/C6OB00340K
file

Janssen Pharmaceuticals, Inc. 2016. Triazoles as nr2b receptor inhibitors. WO2016025917A1. [Patent].

Janssen Pharmaceuticals, Inc. 2016. Pyrazoles as NMDA NR2B receptor inhibitors and their preparation. WO2016025918A1. [Patent].

Reuillon, Tristan, Ward, Simon and Beswick, Paul 2016. AMPA receptor positive allosteric modulators: Potential for the treatment of neuropsychiatric and neurological disorders. Current Topics in Medicinal Chemistry 16 (29) , pp. 3536-3565. 10.2174/1568026616666160627114507
file

Ward, Simon, Dawson, L. A., Konneh, M. and MacDonald, G. 2016. Alzheimer's disease therapeutics - Are we making progress towards a disease-modifying treatment for patients? Highlights from the Society for Medicines Research Symposium, held June 20, 2016. Presented at: Society for Medicines Research Symposium, 20th June 2016. , vol. 7. Prous Science, p. 461. 10.1358/dof.2016.041.07.2516439

Ward, Simon, Pennicott, Lewis E and Beswick, Paul 2015. AMPA receptor-positive allosteric modulators for the treatment of schizophrenia: an overview of recent patent applications. Future Medicinal Chemistry 7 (4) , pp. 473-491. 10.4155/fmc.15.4

Pearl, Laurence H., Schierz, Amanda C., Ward, Simon, Al-Lazikani, Bissan and Pearl, Frances M. G. 2015. Therapeutic opportunities within the DNA damage response. Nature Reviews Cancer 15 (3) , pp. 166-180. 10.1038/nrc3891

Brown, K.A., Davenport, R. and Ward, Simon 2015. Effective and emerging strategies for utilizing structure in drug discovery. Presented at: Society for Medicines Research Meeting, 19th March 2015. , vol. 4. Prous Science, pp. 251-256. 10.1358/dof.2015.040.04.2314768

Meisenberg, C., Gilbert, D. C., Chalmers, A., Haley, V., Gollins, S., Ward, Simon and El-Khamisy, S. F. 2014. Clinical and cellular Roles for TDP1 and TOP1 in modulating colorectal cancer response to irinotecan. Molecular Cancer Therapeutics 14 (2) , pp. 575-585. 10.1158/1535-7163.MCT-14-0762

Meisenberg, Cornelia, Ward, Simon, Schmid, Peter and El-Khamisy, Sherif F 2014. TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to Topotecan. Journal of Cancer Science & Therapy 06 (07) , pp. 258-267. 10.4172/1948-5956.1000280
file

Ward, Simon and Beswick, Paul 2014. What does the aromatic ring number mean for drug design? Expert Opinion on Drug Discovery 9 (9) , pp. 995-1003. 10.1517/17460441.2014.932346

Walker, Sarah, Meisenberg, Cornelia, Bibby, Rachel A., Askwith, Trevor, Williams, Gareth, Rininsland, Frauke H., Pearl, Laurence H., Oliver, Antony W., El-Khamisy, Sherif, Ward, Simon and Atack, John R. 2014. Development of an oligonucleotide-based fluorescence assay for the identification of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors. Analytical Biochemistry 454 , pp. 17-22. 10.1016/j.ab.2014.03.004
file

University of Sussex 2013. Neurodevelopmental disorders. WO 2013/038200 A2. [Patent].

Ward, Simon 2013. Targets and emerging therapies for schizophrenia. Edited by Jeffrey S. Albert and Michael W. Wood [Book Review]. ChemMedChem 8 (3) , p. 529. 10.1002/cmdc.201200589

Convergence Pharmaceutical Ltd 2012. Piperazine derivatives as cav2.2 calcium channel blockers. WO2012098400A1. [Patent].

Convergence Pharmaceuticals Ltd 2012. Tetrazole compounds as calcium channel blockers. WO2012004604A1. [Patent].

Ward, Simon, Harries, Mark, Aldegheri, Laura, Austin, Nigel E., Ballantine, Stuart, Ballini, Elisa, Bradley, Daniel M., Bax, Benjamin, Clarke, Brian P., Harris, Andrew J., Harrison, Stephen A., Melarange, Rosemary A., Mookherjee, Claudette, Mosley, Julie, Dal Negro, Gianni, Oliosi, Beatrice, Smith, Kathrine J., Thewlis, Kevin M., Woollard, Patrick M. and Yusaf, Shahnaz P. 2011. Integration of lead optimization with crystallography for a membrane-bound ion channel target: discovery of a new class of AMPA receptor positive allosteric modulators. Journal of Medicinal Chemistry 54 (1) , pp. 78-94. 10.1021/jm100679e

Davenport, R., Armour, R. and Ward, Simon 2011. Trends in pain research. Presented at: The Society for Medicines Research Pain Meeting, Girton College, Cambridge, UK, 24 March 2011. , vol. 12. Prous Science, pp. 943-948. 10.1358/dof.2011.036.12.1738058

Cowley, P., Hales, N. and Ward, Simon 2011. Trends in medicinal chemistry. Presented at: The Society For Medicines Resarch Symposiun, NHLI, London, UK, 9 December 2010. , vol. 7. Prous Science, pp. 543-549. 10.1358/dof.2011.036.07.1622065

Leslie, Colin P., Biagetti, Matteo, Bison, Silvia, Bromidge, Steven M., Di Fabio, Romano, Donati, Daniele, Falchi, Alessandro, Garnier, Martine J., Jaxa-Chamiec, Albert, Manchee, Gary, Merlo, Giancarlo, Pizzi, Domenica A., Stasi, Luigi P., Tibasco, Jessica, Vong, Antonio, Ward, Simon and Zonzini, Laura 2010. Discovery of 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a potent, selective, and orally active 5-HT1A/B/DReceptor antagonist. Journal of Medicinal Chemistry 53 (23) , pp. 8228-8240. 10.1021/jm100714c

Thewlis, Kevin M., Aldegheri, Laura, Harries, Mark H., Mookherjee, Claudette, Oliosi, Beatrice and Ward, Simon 2010. N-Substituted pyrrolidines and tetrahydrofurans as novel AMPAR positive modulators. Bioorganic & Medicinal Chemistry Letters 20 (23) , pp. 7116-7119. 10.1016/j.bmcl.2010.09.062

Ward, Simon, Harries, Mark, Aldegheri, Laura, Andreotti, Daniele, Ballantine, Stuart, Bax, Benjamin D., Harris, Andrew J., Harker, Andy J., Lund, Jesper, Melarange, Rosemary, Mingardi, Anna, Mookherjee, Claudette, Mosley, Julie, Neve, Marta, Oliosi, Beatrice, Profeta, Roberto, Smith, Kathrine J., Smith, Paul W., Spada, Simone, Thewlis, Kevin M. and Yusaf, Shahnaz P. 2010. Discovery of N-[(2S)-5-(6-Fluoro-3-pyridinyl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator. Journal of Medicinal Chemistry 53 (15) , pp. 5801-5812. 10.1021/jm1005429

Glaxo Group Limited 2010. Compounds which potentiate the ampa receptor and uses thereof in medicine. WO2010066658A1. [Patent].

Glaxo Group Limited 2010. N- inden- 2 -yl- isopropylsulfonamides as ampa receptor potentiators. WO2010057865A1. [Patent].

Ward, Simon, Bax, Benjamin D. and Harries, Mark 2010. Challenges for and current status of research into positive modulators of AMPA receptors. British Journal of Pharmacology 160 (2) , pp. 181-190. 10.1111/j.1476-5381.2010.00726.x

Glaxo Group Limited 2010. Compounds which potentiate the ampa receptor and uses thereof in medicine. WO2010037760. [Patent].

Glaxo Group Limited 2010. Pyrazolo [1, 5-a] pyrimidine derivatives. WO2010007074A1. [Patent].

Ward, Simon and Watson, Jeannette M. 2010. Recent advances in the discovery of selective and non-selective 5-HT1D receptor ligands. Current Topics in Medicinal Chemistry 10 (5) , pp. 479-492. 10.2174/156802610791111533

Ward, Simon and Harries, Mark 2010. Recent advances in the discovery of selective AMPA receptor positive allosteric modulators. Current Medicinal Chemistry 17 (30) , pp. 3503-3513. 10.2174/092986710792927840

Glaxo Group Limited 2009. Compounds which potentiate the ampa receptor and uses thereof in medicine. WO2009092713A1. [Patent].

Glaxo Group Limited 2009. Compounds which potentiate the ampa receptor and uses thereof in medicine. WO2009092712A1. [Patent].

Glaxo Group Limited 2009. Compounds which potentiate the ampa receptor and uses thereof in medicine. WO2009080637A1. [Patent].

Glaxo Group Limited 2009. Thiazoles which potentiate ampa receptor and medicinal uses thereof. WO2009053449A1. [Patent].

Glaxo Group Limited 2009. Compounds which potentiate ampa receptor and uses thereof in medicine. WO2009053448A1. [Patent].

Alderton, W., Karran, E. and Ward, Simon 2009. Current and future perspectives in psychiatric drug discovery. Presented at: Society for Medicines Research Symposium, GlaxoSmithKline, Harlow, U.K, 12 March 2009. , vol. 6. Thomson Reuters, pp. 360-364. 10.1358/dnp.2009.22.6.1380328

Ward, Simon, Eddershaw, Peter, Flynn, Sean T., Gordon, Laurie, Lovell, Peter J., Moore, Susan H., Scott, Claire M., Smith, Paul W., Thewlis, Kevin M. and Wyman, Paul A. 2008. Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands-Part II. Biorganic and Medicinal Chemistry Letters 19 (2) , pp. 428-432. 10.1016/j.bmcl.2008.11.052

Glaxo Group Limited 2008. Compounds which potentiate AMPA receptor and uses thereof in medicine. WO2008113795. [Patent].

Glaxo Group Limited 2008. Compounds which potentiate ampa receptor and uses thereof in medicine. WO2008110566A1. [Patent].

Glaxo Group Limited 2008. Compounds which potentiate ampa receptor and uses therof in medicine. WO2008148832A1. [Patent].

Glaxo Group Limited 2008. Compounds which potentiate ampa receptor and uses thereof in medicine. WO2008053031A1. [Patent].

Ward, Simon, Eddershaw, Peter J., Scott, Claire M., Gordon, Laurie J., Lovell, Peter J., Moore, Susan H., Smith, Paul W., Starr, Kathryn R., Thewlis, Kevin M. and Watson, Jeannette M. 2008. Discovery of potent, orally bioavailable, selective 5-HT1A/B/DReceptor antagonists. Journal of Medicinal Chemistry 51 (10) , pp. 2887-2890. 10.1021/jm8001444

Gillespie, Roger J., Adams, David R., Bebbington, David, Benwell, Karen, Cliffe, Ian A., Dawson, Claire E., Dourish, Colin T., Fletcher, Allan, Gaur, Suneel, Giles, Paul R., Jordan, Allan M., Knight, Antony R., Knutsen, Lars J.S., Lawrence, Anthony, Lerpiniere, Joanne, Misra, Anil, Porter, Richard H.P., Pratt, Robert M., Shepherd, Robin, Upton, Rebecca, Ward, Simon, Weiss, Scott M. and Williamson, Douglas S. 2008. Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives. Biorganic and Medicinal Chemistry Letters 18 (9) , pp. 2916-2919. 10.1016/j.bmcl.2008.03.075

Glaxo Group Limited 2007. Compounds which potentiate ampa receptor and uses thereof in medicine. WO2007122241A1. [Patent].

Glaxo Group Limited 2007. Compounds which potentiate ampa receptor and uses thereof in medicine. WO2007107539A1. [Patent].

Glaxo Group Limited 2007. 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia. WO2007090840A1. [Patent].

Glaxo Group Limited 2007. Compounds which potentiate glutamate receptor and uses thereof in medicine. WO2007090841A1. [Patent].

Ward, Simon, Johnson, Christopher N., Lovell, Peter J., Scott, Claire M., Smith, Paul W., Stemp, Geoffrey, Thewlis, Kevin M., Vong, Antonio K. and Watson, Jeannette M. 2007. Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands. Biorganic and Medicinal Chemistry Letters 17 (18) , pp. 5214-5217. 10.1016/j.bmcl.2007.06.078

Ahmad, Nadia M., Rodeschini, Vincent, Simpkins, Nigel S., Ward, Simon and Blake, Alexander J. 2007. Synthesis of polyprenylated acylphloroglucinols using bridgehead lithiation: the total synthesis of racemic clusianone and a formal synthesis of racemic garsubellin A. The Journal of Organic Chemistry 72 (13) , pp. 4803-4815. 10.1021/jo070388h

Ahmad, Nadia M., Rodeschini, Vincent, Simpkins, Nigel S., Ward, Simon and Wilson, Claire 2007. Synthetic studies towards garsubellin A: synthesis of model systems and potential mimics by regioselective lithiation of bicyclo[3.3.1]nonane-2,4,9-trione derivatives from catechinic acid. Organic & Biomolecular Chemistry 5 (12) , pp. 1924-1934. 10.1039/b704311b

Craig, Donald, Hyland, Christopher J. T. and Ward, Simon 2006. Stereoselective synthesis of (-)-trachelanthamidine (IV) via palladium-catalyzed intramolecular allylation. Chem Inform 37 (50) 10.1002/chin.200650213

Lovell, Peter J., Blaney, Frank E., Goodacre, Caroline J., Scott, Claire M., Smith, Paul W., Starr, Kathryn R., Thewlis, Kevin M., Vong, Antonio K.K., Ward, Simon and Watson, Jeannette M. 2006. 3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors. Bioorganic and Medicinal Chemistry Letters 17 (4) , pp. 1033-1036. 10.1016/j.bmcl.2006.11.031

Glaxo Group Limited 2006. Acylated piperidihes as glycine transporter inhibitors. WO2006094842. [Patent].

Glaxo Group Limited 2006. Compounds which potentiate glutamate receptor and uses thereof in medicine. WO2006087169A1. [Patent].

Glaxo Group Limited 2006. Glycine transport inhibitors. WO2006067417A1. [Patent].

Glaxo Group Limited 2006. Glycine transport inhibitors. WO2006067423A1. [Patent].

Glaxo Group Limited 2006. Compounds which potentiate glutamate receptor and uses thereof in medicine. WO 2006015828. [Patent].

Glaxo Group Limited 2006. Compounds which potentiate glutamate receptor and uses thereof in medicine. WO 2006015827. [Patent].

Glaxo Group Limited 2006. Compounds which potentiate glutamate receptor and uses thereof in medicine. WO2006015829. [Patent].

Craig, Donald, Hyland, Christopher J. T. and Ward, Simon 2005. Stereoselective γ-lactam synthesis via palladium-catalysed intramolecular allylation. Chemical Communications- Royal Society of Chemistry (27) , pp. 3439-3441. 10.1039/b504731e

Ward, Simon, Harrington, Frank P., Gordon, Laurie J., Hopley, Susanna C., Scott, Claire M. and Watson, Jeannette M. 2005. Discovery of the first potent, selective 5-Hydroxytryptamine1D receptor antagonist [Letter]. Journal of Medicinal Chemistry 48 (10) , pp. 3478-3480. 10.1021/jm049039v

Glaxo Group Limited 2005. Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors. WO 2005014552. [Patent].

Glaxo Group Limited 2004. Benzoxazinone derivatives having affinity for 5- ht receptors, their preparation and use. WO 2004099198. [Patent].

Glaxo Group Limited 2004. Benzoxazinone derivatives, their preparation and use. WO2004099196A1. [Patent].

Glaxo Group Limited 2003. Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors. WO2003068236A1. [Patent].

Glaxo Group Limited 2003. Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders. WO2003068760A2. [Patent].

Glaxo Group Limited 2003. Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors. WO2003068771A1. [Patent].

Glaxo Group Limited 2003. Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy. WO2003068772A1. [Patent].

Vernalis Research Limited 2000. 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission. WO2000044371A1. [Patent].

Vernalis Research Limited 2000. 4-quinolinemethanol derivatives as purine receptor antagonists (i). WO2000013681A2. [Patent].

Cerebrus Pharmaceuticals Limited 1999. 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission. WO1999031051A1. [Patent].

Adger, Brian M., Dyer, Ulrich C., Lennon, Ian C., Tiffin, Peter D. and Ward, Simon 1998. A novel synthesis of tert-leucine via a Leuckart type reaction. Tetrahedron Letters 38 (12) , pp. 2153-2154. 10.1016/S0040-4039(97)00269-4

Ward, Simon, Holmes, Andrew B. and McCague, Ray 1997. Total synthesis of carbocyclic nikkomycin C. Chemical Communications- Royal Society of Chemistry (21) , pp. 2085-2086. 10.1039/a705825j

Congreve, Miles S., Davison, Edwin C., Fuhry, Mary Ann M., Holmes, Andrew B., Payne, Andrew N., Robinson, R. Anthony and Ward, Simon 1993. Selective cleavage of benzyl ethers [Letter]. Synlett 1993 (09) , pp. 663-664. 10.1055/s-1993-22563

Davis, A. M. and Ward, Simon The handbook of medicinal chemistry principles and practice. Cambridge: Royal Society of Chemistry.

Ward, Simon AMPA receptor positive allosteric modulators a case history. In: Cox, B. and Gosling, M. eds. Ion Channel Drug Discovery, Vol. 39. RSC Drug Discovery Series, vol. 39. Cambridge: Royal Society of Chemistry, pp. 105-134.

Ward, Simon DNA damage repair pathways and synthetic lethality. In: Lackey, K. and Roth, B. eds. Medicinal Chemistry Approaches to Personalized Medicine, Vol. 59. Wiley-Blackwell, pp. 183-210.

Ward, Simon Neurotransmitters and other non-opiate central mechanisms. In: Allerton, C. ed. Pain Therapeutics: Current and Future Paradigms, RSC Drug Discovery Series, vol. 35. Cambridge: Royal Society of Chemistry, pp. 171-196.

Ward, Simon Discovery and clinical data for a novel AMPA receptor positive modulator. In: Rankovic, Z., Hargreaves, R. and Bingham, M. eds. Drug Discovery for Psychiatric Disorders, RSC Drug Discovery Series, vol. 28. Cambridge: Royal Society of Chemistry, pp. 99-122. (10.1039/9781849734943)

This list was generated on Mon Dec 9 08:33:40 2019 GMT.